Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Andrews

Showing results (21-30 of 368) with videos related to

Pageof 37
Sort By:
Alimentary Pharmacology & Therapeutics|December 5, 2012
Commentary: IBD combination therapy - adalimumab plus immunosuppressantsJ M Andrews
The Journal of Antimicrobial Chemotherapy|July 15, 2006
BSAC standardized disc susceptibility testing method (version 5)J M Andrews,
British Journal of Plastic Surgery|July 1, 1979
Extensive malignancies of facial skin treated by perfusion with 5-fluorouracil and conservative excisionJ M Andrews
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vitro activities of two glycylcyclinesR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|August 1, 1991
Susceptibility testing of urinary tract pathogens to norfloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|August 2, 2001
In vitro susceptibility testing of BMS-284756 by the BSAC standardized disc testing methodJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|November 1, 1984
A comparison of the homogeneous enzyme immunoassay and polarization fluoroimmunoassay of gentamicinJ M Andrews, R Wise
Journal of Clinical Pathology|December 1, 1977
Letter to the editorR Wise, J M Andrews
Journal of Chemotherapy (Florence, Italy)|May 1, 1989
The in vitro activity of tigemonam: a comparison with other antimicrobial agentsJ M Andrews, R Wise
Alimentary Pharmacology & Therapeutics|August 7, 2013
Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapyA Agarwal, J M Andrews
Pageof 37

Showing results (21-30 of 368) with videos related to

Sort By:
Pageof 37
Alimentary Pharmacology & Therapeutics|December 5, 2012
Commentary: IBD combination therapy - adalimumab plus immunosuppressantsJ M Andrews
The Journal of Antimicrobial Chemotherapy|July 15, 2006
BSAC standardized disc susceptibility testing method (version 5)J M Andrews,
British Journal of Plastic Surgery|July 1, 1979
Extensive malignancies of facial skin treated by perfusion with 5-fluorouracil and conservative excisionJ M Andrews
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vitro activities of two glycylcyclinesR Wise, J M Andrews
The Journal of Antimicrobial Chemotherapy|August 1, 1991
Susceptibility testing of urinary tract pathogens to norfloxacinJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|August 2, 2001
In vitro susceptibility testing of BMS-284756 by the BSAC standardized disc testing methodJ M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|November 1, 1984
A comparison of the homogeneous enzyme immunoassay and polarization fluoroimmunoassay of gentamicinJ M Andrews, R Wise
Journal of Clinical Pathology|December 1, 1977
Letter to the editorR Wise, J M Andrews
Journal of Chemotherapy (Florence, Italy)|May 1, 1989
The in vitro activity of tigemonam: a comparison with other antimicrobial agentsJ M Andrews, R Wise
Alimentary Pharmacology & Therapeutics|August 7, 2013
Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapyA Agarwal, J M Andrews
Pageof 37